Recruiting

Genomic Biorepository

Sponsor:

Rady Pediatric Genomics & Systems Medicine Institute

Code:

NCT02917460

Conditions

Genetic Diseases

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Interventions

Genomic sequencing and molecular diagnostic results, if any

Study Details

Brief summary:

Rady Children's Institute for Genomic Medicine (RCI) will collect biological samples (such as blood), derived genomic sequences (from DNA and RNA), and clinical features in a Biorepository as a standardized resource for future research studies. The purpose of the Genomic Institute Biorepository is to provide consented samples and data for basic and clinical research related to the genomic cause and treatment of childhood disease, and, in the future, as reference (Quality Control) data to improve the ability to make clinical diagnoses or clinical decisions.

In addition, the Biorepository will provide a mechanism for making a diagnosis of a genetic disease. That is, once genomic sequences have been derived from biological samples, they will be immediately analyzed. If a genetic disease is identified that appears to explain an affected child's clinical features, then those results will be confirmed by the medically accepted standard, and placed in the electronic health record.

Conditions

Genetic Diseases

Study ID

NCT02917460

Start date

Jul, 2016

Status verified date

Dec, 2022

Completion date

Dec, 2050

Anticipated

Primary completion date

Dec, 2050

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • All ages, races, genders, ethnicities, and health status will be eligible for participation. Enrollment will include that following vulnerable populations: pregnant women, neonates, fetuses, those with cognitive disabilities, pediatric patients, minorities, and employees.

Exclusion Criteria:

  • None

Study Design

Enrollment

102000 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Enrollees

Enrollment of healthy and affected subjects to collect samples and data for a pediatric genomic Biorepository. Data includes genomic sequencing and resultant molecular diagnostic results, if any.

Interventions

Genomic sequencing and molecular diagnostic results, if any

Samples will be stored in the pediatric genomic Biorepository. A subset of samples will undergo genetic/genomic analysis.

Primary outcome measure

  • Number of samples enrolled per year [ Time Frame: Yearly through study completion estimated to be 40 years ]

Central Contacts and Locations

Central contacts

Locations

Rady Pediatric Genomics & Systems Medicine Institute

Recruiting

San Diego, California, United States, 92123

Contacts

More Information

Sponsor

Rady Pediatric Genomics & Systems Medicine Institute

Last update posted

Dec 12, 2022

Last verified

Dec, 2022

Keywords

  • Rady
  • Pediatric
  • Genomic
  • Precision medicine
  • Biorepository

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Rady Pediatric Genomics & Systems Medicine Institute on 2022-12-12.